Charles Schwab Investment Management Inc. Grows Stock Holdings in DENTSPLY SIRONA Inc. $XRAY

Charles Schwab Investment Management Inc. grew its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 0.3% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,108,014 shares of the medical instruments supplier’s stock after buying an additional 6,881 shares during the period. Charles Schwab Investment Management Inc. owned 1.06% of DENTSPLY SIRONA worth $31,494,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in XRAY. Vanguard Group Inc. raised its stake in shares of DENTSPLY SIRONA by 2.8% in the 1st quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier’s stock valued at $309,864,000 after purchasing an additional 557,329 shares in the last quarter. Bank of Nova Scotia boosted its holdings in shares of DENTSPLY SIRONA by 347.5% in the first quarter. Bank of Nova Scotia now owns 84,254 shares of the medical instruments supplier’s stock valued at $1,259,000 after acquiring an additional 65,426 shares in the last quarter. Bayforest Capital Ltd boosted its holdings in shares of DENTSPLY SIRONA by 822.2% in the first quarter. Bayforest Capital Ltd now owns 20,676 shares of the medical instruments supplier’s stock valued at $309,000 after acquiring an additional 18,434 shares in the last quarter. Federated Hermes Inc. boosted its holdings in shares of DENTSPLY SIRONA by 38.6% in the first quarter. Federated Hermes Inc. now owns 234,604 shares of the medical instruments supplier’s stock valued at $3,505,000 after acquiring an additional 65,300 shares in the last quarter. Finally, ARK Investment Management LLC boosted its holdings in DENTSPLY SIRONA by 17.1% during the first quarter. ARK Investment Management LLC now owns 160,773 shares of the medical instruments supplier’s stock worth $2,402,000 after buying an additional 23,448 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

NASDAQ XRAY opened at $14.03 on Wednesday. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The firm has a market capitalization of $2.80 billion, a price-to-earnings ratio of -2.96, a P/E/G ratio of 0.86 and a beta of 0.94. The company’s fifty day moving average is $15.37 and its two-hundred day moving average is $15.60. DENTSPLY SIRONA Inc. has a 52-week low of $12.16 and a 52-week high of $27.48.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.02. The company had revenue of $936.00 million for the quarter, compared to analyst estimates of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The business’s quarterly revenue was down 4.9% on a year-over-year basis. During the same period last year, the business posted $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Equities research analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 4.6%. The ex-dividend date is Friday, September 26th. DENTSPLY SIRONA’s payout ratio is -13.50%.

Analysts Set New Price Targets

Several equities research analysts recently commented on XRAY shares. Piper Sandler reduced their price target on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating for the company in a research report on Wednesday, April 30th. Barrington Research cut their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating for the company in a research report on Friday, August 8th. Stifel Nicolaus cut their target price on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a research report on Friday, August 8th. Wells Fargo & Company cut their target price on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating for the company in a research report on Friday, August 8th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a research report on Monday, July 21st. Two research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $18.64.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.